Showing results (421-430 of 461) with videos related to

Sort By:
Pageof 47
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|January 17, 2025
The "CUPCAKE" technique (coiled underlying pseudoaneurysm contained by a woven endobridge device) for treating intracranial aneurysms with atypical morphologyViktorija Vainauskaite, Yifan Ren, Mohamed Nasra, et al.
JAMA|May 12, 2017
Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non-Small Cell Lung Cancer: The SELECT-1 Randomized Clinical TrialPasi A Jänne, Michel M van den Heuvel, Fabrice Barlesi, et al.
European Journal of Pharmacology|August 31, 2020
Preclinical characterization of itacitinib (INCB039110), a novel selective inhibitor of JAK1, for the treatment of inflammatory diseasesMaryanne Covington, Xin He, Monika Scuron, et al.
Regulatory Toxicology and Pharmacology : RTP|October 28, 2015
A global initiative to refine acute inhalation studies through the use of 'evident toxicity' as an endpoint: Towards adoption of the fixed concentration procedureFiona Sewell, Ian Ragan, Tim Marczylo, et al.
Frontiers in Immunology|July 9, 2019
Imaging Mass Cytometry and Single-Cell Genomics Reveal Differential Depletion and Repletion of B-Cell Populations Following Ofatumumab Treatment in Cynomolgus MonkeysDiethilde Theil, Paul Smith, Catherine Huck, et al.
Alimentary Pharmacology & Therapeutics|December 22, 2021
A propensity score-matched, real-world comparison of ustekinumab vs vedolizumab as a second-line treatment for Crohn's disease. The Cross Pennine study IIMarco Vincenzo Lenti, Vivien Dolby, Tanya Clark, et al.
Pediatrics|September 18, 2020
IDeA States Pediatric Clinical Trials Network for Underserved and Rural CommunitiesRobert D Annett, Sheva Chervinskiy, Thomas H Chun, et al.
Cancers|June 1, 2019
PARP Inhibition Increases the Response to Chemotherapy in Uveal MelanomaLeanne de Koning, Didier Decaudin, Rania El Botty, et al.
Physiological Genomics|December 24, 2009
EDNRA variants associate with smooth muscle mRNA levels, cell proliferation rates, and cystic fibrosis pulmonary disease severityRebecca Darrah, Edward McKone, Clare O'Connor, et al.
British Journal of Haematology|November 28, 2008
Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trialBarry W Hancock, Wendi Qian, David Linch, et al.
Pageof 47